Home > Insider Trading > Filing (0001179110-13-008953)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1065087	Albany Molecular Research Inc	AMRI	Services-Commercial Physical & Biological Research (8731)	141742717

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1512062	J Bruce Sargent	21 Corporate Circle Po Box 15098 Albany NY 12033	Sr Vp, Drug Discovery	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-22	7,500	$2.93	64,590	No	4	M	Direct
Common Stock	Disposition	2013-05-22	7,500	$10.97	57,090	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase Common Stock	Disposition	2013-05-22	7,500	$2.93	7,500	$2.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,500		2022-02-17	No	4	M	Direct

Footnotes

The reported price represents the weighted average sales price for such shares. The actual range of sales prices for such shares was $10.95 - $11.00. Upon request of the Commission, the exact number of shares sold at each price will be provided.
50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant. Performance based grant will vest at 25% on each anniversary of the grant date through 2016 if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date. If the foregoing criteria are not met on any anniversary date, 25% of the shares of restricted stock/options under this award will immediately be forfeited. The 7,500 shares being exercised represent the first anniversary vesting of 25% of both the time based and performance based grants. The remaining 75% of each grant is not yet exercisable.